CAMPBELLVILLE, ON, June 26 /CNW/ - NIR Diagnostics Inc. (TSX Venture: NID - News), a leading-edge developer of handheld spectroscopy based medical instruments, today announced grants of stock options to five outside directors of the Company under the 2003 Stock Option Plan (the “Plan”). At a meeting on June 20, 2006, the Board of Directors of the Company granted such outside directors an aggregate of 100,000 stock options at an exercise price of $0.19 per option. In accordance with the Plan, the options have a term of 5 years and vest over an eighteen month.
